Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Safety and Feasibility of an Integrated Fabric-Type Orthosis for Gait and Balance Improvement in Geriatric Patients

12 de novembro de 2026 atualizado por: Seoul National University Hospital

Safety and Feasibility of an Integrated Fabric- Type Orthosis With Muscle-Mimicking and Proprioception-Enhancing Functions for Improving Gait and Balance in Geriatric Patients: Pilot Clinical Trial

This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

30

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: junghyun kim, prof
  • Número de telefone: 82+1088632341
  • E-mail: kiking0@naver.com

Locais de estudo

    • Jongno
      • Seoul, Jongno, Coréia do Sul, 03080
        • Recrutamento
        • Seoul National University Hospital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

65 anos e mais velhos (Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

Eligibility for participation in the study requires that all the following criteria are met:

  1. Age: Participants must be 65 years of age or older.

  2. Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.

  3. Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:

    • Muscle Strength: Handgrip strength of <28 kg for men and <18 kg for women.
    • Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
    • Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass <7.0 kg/m² for men and <5.7 kg/m² for women. (2)Diabetes:
    • Diagnosed distal symmetric polyneuropathy.
    • Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
    • Kellgren-Lawrence grade ≥2.
    • Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).

Exclusion Criteria:

Individuals meeting any of the following criteria will be excluded from study participation:

  1. Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.

  2. Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.

  3. Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.

  4. Independent Walking Inability: Cannot walk independently without the aid of a walking device.

  5. Other Significant Diseases or Conditions:

    • Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
    • Orthopedic or musculoskeletal conditions severely affecting lower limb function.
    • Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
    • Respiratory diseases requiring regular oxygen therapy.
    • Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
    • Severe psychiatric disorders like schizophrenia or bipolar disorder.
  6. Other Exclusionary Factors:

    • Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
    • Severe back pain or any other condition affecting mobility not already listed.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Integrated Fabric-Type Orthosis Evaluation

Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults.

A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.

Outros nomes:
  • Soft Exosuit

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Blood Pressure From Before to After Functional Assessment
Prazo: Immediately before and after the functional assessment at each study visit

Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Heart Rate From Before to After Functional Assessment
Prazo: Immediately before and after the functional assessment at each study visit

Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Perceived Exertion From Before to After Functional Assessment
Prazo: Immediately before and after the functional assessment at each study visit

Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion.

Immediately before and after the functional assessment at each study visit
Change in Pain Intensity From Before to After Functional Assessment
Prazo: Immediately before and after the functional assessment at each study visit

Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and after the functional assessment at each study visit

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
6-Minute Walk Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess gait speed and short-distance walking performance under different orthosis conditions.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
20-Meter Walk Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess walking speed and gait performance over a longer walking distance.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Static One-Leg Standing Balance Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate static balance ability by measuring the duration participants can maintain single-leg standing.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Postural Sway
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Passive Joint Position Reproduction Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Active Joint Position Reproduction Test
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Participant Satisfaction
Prazo: Immediately post-brace activation (power on)

To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis.

Immediately post-brace activation (power on)
Gait Speed
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Gait speed measured using the GAITRite system, reported in meters per second (m/s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Cadence
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Cadence measured using the GAITRite system, reported in steps per minute (steps/min).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Length
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Length
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Single Support Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Single support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Double Support Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Double support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stance Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stance time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Swing Time
Prazo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Swing time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Investigadores

  • Diretor de estudo: hyungik shin, prof, Seoul National University Hospital

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

17 de junho de 2026

Conclusão Primária (Estimado)

31 de dezembro de 2027

Conclusão do estudo (Estimado)

31 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

21 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • H-2603-077-1726

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .